Quick Answer
Niagen Bioscience, Inc. reported Total Assets of $106.41 million for the year ending 2025.
- Niagen Bioscience, Inc. showed an increase of +55.8% in Total Assets from 2024 to 2025.
- This data is from Niagen Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $7.06 million | Q3 2011: $7.31 million | Q1 2012: $12.92 million | Q2 2012: $10.20 million | Q3 2012: $9.43 million | Q1 2013: $10.72 million | Q2 2013: $10.95 million | Q3 2013: $7.78 million | Q1 2014: $8.47 million | Q2 2014: $8.88 million | Q3 2014: $8.70 million | Q1 2015: $10.98 million | Q2 2015: $14.22 million | Q3 2015: $15.05 million | Q1 2016: $16.53 million | Q2 2016: $17.78 million | Q3 2016: $18.76 million | Q1 2017: $21.05 million | Q2 2017: $32.92 million | Q3 2017: $41.80 million | Q1 2018: $57.45 million | Q2 2018: $52.17 million | Q3 2018: $47.02 million | Q1 2019: $41.93 million | Q2 2019: $44.54 million | Q3 2019: $43.14 million | Q1 2020: $35.61 million | Q2 2020: $41.99 million | Q3 2020: $37.42 million | Q1 2021: $68.99 million | Q2 2021: $65.84 million | Q3 2021: $60.45 million | Q1 2022: $52.93 million | Q2 2022: $46.61 million | Q3 2022: $45.67 million | Q1 2023: $53.77 million | Q2 2023: $53.17 million | Q3 2023: $53.48 million | Q1 2024: $54.08 million | Q2 2024: $54.04 million | Q3 2024: $56.52 million | Q1 2025: $81.34 million | Q2 2025: $91.53 million | Q3 2025: $98.14 million.
- Over the full 16 years of available data (2010 to 2025), Niagen Bioscience, Inc.'s Total Assets has grown by 1,535.2%.
- Historical annual values: Fiscal year 2025: $106.41 million | Fiscal year 2024: $68.28 million | Fiscal year 2023: $54.96 million | Fiscal year 2022: $54.06 million | Fiscal year 2021: $57.84 million | Fiscal year 2020: $38.36 million | Fiscal year 2019: $40.25 million | Fiscal year 2018: $42.23 million | Fiscal year 2017: $62.72 million | Fiscal year 2016: $19.75 million | Fiscal year 2015: $18.75 million | Fiscal year 2014: $11.52 million | Fiscal year 2013: $8.99 million | Fiscal year 2012: $9.03 million | Fiscal year 2011: $6.27 million | Fiscal year 2010: $6.51 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: